Search research articles
Contact Us
Filters
Showing results (261-270 of 306) with videos related to
Page
of 31
Sort By:
The Lancet. Neurology
|
December 17, 2008
Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology
Alexis Arzimanoglou, Jacqueline French, Warren T Blume, et al.
Epilepsia
|
July 20, 2005
A comparative study of the effect of carbamazepine and valproic acid on the pharmacokinetics and metabolic profile of topiramate at steady state in patients with epilepsy
Dorit Mimrod, Luigi M Specchio, Malka Britzi, et al.
Epilepsia
|
December 6, 2011
Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments
Chiara Luoni, Francesca Bisulli, Maria Paola Canevini, et al.
CNS Drugs
|
October 23, 2009
Visual field loss in patients with refractory partial epilepsy treated with vigabatrin: final results from an open-label, observational, multicentre study
John M Wild, Catherine Chiron, Hyosook Ahn, et al.
JAMA Neurology
|
October 9, 2023
Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy: A Phase 2b Randomized Clinical Trial
Jacqueline A French, Roger J Porter, Emilio Perucca, et al.
CNS Drugs
|
July 25, 2014
Off-label prescribing of antiepileptic drugs in pharmacoresistant epilepsy: a cross-sectional drug utilization study of tertiary care centers in Italy
Valentina Franco, Maria Paola Canevini, Giuseppe Capovilla, et al.
Epilepsia
|
December 15, 2015
The current state of epilepsy guidelines: A systematic review
Khara M Sauro, Samuel Wiebe, Colin Dunkley, et al.
Neurology
|
July 1, 2020
Does screening for adverse effects improve health outcomes in epilepsy? A randomized trial
Valentina Franco, Maria Paola Canevini, Giovambattista De Sarro, et al.
BMJ (Clinical Research Ed.)
|
March 29, 2019
Low risk pragmatic trials do not always require participants' informed consent
Rafael Dal-Ré, Cristina Avendaño-Solà, Brigitte Bloechl-Daum, et al.
Orphanet Journal of Rare Diseases
|
June 16, 2025
Blueprint for clinical N-of-1 strategies with off-label precision treatments in monogenic epilepsies
Victoria M Defelippe, Eva H Brilstra, Willem M Otte, et al.
Page
of 31
Search research articles
Search
Showing results (261-270 of 306) with videos related to
Sort By:
Page
of 31
The Lancet. Neurology
|
December 17, 2008
Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology
Alexis Arzimanoglou, Jacqueline French, Warren T Blume, et al.
Epilepsia
|
July 20, 2005
A comparative study of the effect of carbamazepine and valproic acid on the pharmacokinetics and metabolic profile of topiramate at steady state in patients with epilepsy
Dorit Mimrod, Luigi M Specchio, Malka Britzi, et al.
Epilepsia
|
December 6, 2011
Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments
Chiara Luoni, Francesca Bisulli, Maria Paola Canevini, et al.
CNS Drugs
|
October 23, 2009
Visual field loss in patients with refractory partial epilepsy treated with vigabatrin: final results from an open-label, observational, multicentre study
John M Wild, Catherine Chiron, Hyosook Ahn, et al.
JAMA Neurology
|
October 9, 2023
Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy: A Phase 2b Randomized Clinical Trial
Jacqueline A French, Roger J Porter, Emilio Perucca, et al.
CNS Drugs
|
July 25, 2014
Off-label prescribing of antiepileptic drugs in pharmacoresistant epilepsy: a cross-sectional drug utilization study of tertiary care centers in Italy
Valentina Franco, Maria Paola Canevini, Giuseppe Capovilla, et al.
Epilepsia
|
December 15, 2015
The current state of epilepsy guidelines: A systematic review
Khara M Sauro, Samuel Wiebe, Colin Dunkley, et al.
Neurology
|
July 1, 2020
Does screening for adverse effects improve health outcomes in epilepsy? A randomized trial
Valentina Franco, Maria Paola Canevini, Giovambattista De Sarro, et al.
BMJ (Clinical Research Ed.)
|
March 29, 2019
Low risk pragmatic trials do not always require participants' informed consent
Rafael Dal-Ré, Cristina Avendaño-Solà, Brigitte Bloechl-Daum, et al.
Orphanet Journal of Rare Diseases
|
June 16, 2025
Blueprint for clinical N-of-1 strategies with off-label precision treatments in monogenic epilepsies
Victoria M Defelippe, Eva H Brilstra, Willem M Otte, et al.
Page
of 31